PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34482362-5	2021	We found that pharmacologic inhibition of neddylation using a small-molecule inhibitor, MLN4924/Pevonedistat, increases the expression of the NK cell-activating receptor NKG2D ligands MICA and MICB on the plasma membrane of different MM cell lines and patient-derived PCs, leading to enhanced NK cell degranulation.	pevonedistat	88-95	MHC class I polypeptide-related sequence B	Homo sapiens	193-197	
34482362-5	2021	We found that pharmacologic inhibition of neddylation using a small-molecule inhibitor, MLN4924/Pevonedistat, increases the expression of the NK cell-activating receptor NKG2D ligands MICA and MICB on the plasma membrane of different MM cell lines and patient-derived PCs, leading to enhanced NK cell degranulation.	pevonedistat	96-108	MHC class I polypeptide-related sequence B	Homo sapiens	193-197	
34482362-7	2021	Differently, MLN4924/Pevonedistat induced accumulation of MICB on the plasma membrane with no change of its mRNA levels, indicating a post-translational regulatory mechanism.	pevonedistat	13-20	MHC class I polypeptide-related sequence B	Homo sapiens	58-62	
34482362-7	2021	Differently, MLN4924/Pevonedistat induced accumulation of MICB on the plasma membrane with no change of its mRNA levels, indicating a post-translational regulatory mechanism.	pevonedistat	21-33	MHC class I polypeptide-related sequence B	Homo sapiens	58-62